8412 (8412) Fair Value & Analysis

Consumer Cyclical · Market cap HK$39.7M

8 8412 8412 · HK

PriceHK$0.3250

Fair ValueHK$0.3000

Upside-7.7%

Quality34/100

Watch 8412 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.2200 – HK$0.3800

Fair value as of: Jul 3, 2026

From 3 valuation models · updated today

Share price +8.3% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2450 – HK$0.4500 · fair‑value band HK$0.2200 – HK$0.3800 · the HK$0.3250 price screens above the HK$0.3000 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8412 (8412) currently trades at HK$0.3250, while our model-based Fair Value estimate is HK$0.3000 — implying the stock looks roughly 7.7% overvalued today. We read business quality at 34/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 8412 generated revenue of HK$39.9M at a net margin of -2.1%. Revenue grew 8.5% year over year. Net debt stands at HK$2.3M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) HK$39.9M

Revenue growth (YoY) +8.5%

Net margin -2.1%

Return on equity -2,106%

Free cash flow −HK$5.2M FY2025

Operating margin -38.4%

More key figures

Net debt HK$2.3M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8412 reported revenue of HK$38.8M in FY2025 versus HK$24.4M in FY2021, a compound +12.3%/yr. Reported net income was −HK$4.9M in FY2025.

Revenue +12.3%/yr

FY21 HK$24.4M

FY22 HK$50.3M

FY23 HK$78.0M

FY24 HK$89.2M

FY25 HK$38.8M

Net income

FY21 −HK$36.9M

FY22 −HK$8.9M

FY23 HK$3.6M

FY24 −HK$17.1M

FY25 −HK$4.9M

Is 8412 fairly valued? → Check now

Similar stocks

6 more Restaurants stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
McDonald's Corporation MCD	4,928 MXN	1,948 MXN	-60%
Starbucks Corporation SBUX	C$27.68	C$7.21	-74%
Compass Group CMPGF	$32.59	$24.90	-24%
Chipotle Mexican Grill, Inc CMGS	C$12.49	C$9.29	-26%
Yum! Brands, Inc YUM	$151.08	$91.11	-40%
Restaurant Brands International Inc QSR	$72.66	$34.01	-53%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8412 (8412) undervalued?

As of Jul 3, 2026, our model estimates a fair value of HK$0.3000 versus a price of HK$0.3250 — about −8% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 8412?

Our model-based fair value for 8412 is HK$0.3000 (as of Jul 3, 2026), built from audited fundamentals. The current price is HK$0.3250.

What is the quality score of 8412?

8412 has a Quality Score of 34/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8412 (8412)?

8412 reported trailing-twelve-month revenue of about HK$39.9M (latest available figure, as of Jul 3, 2026).

What is the net profit margin of 8412?

The net profit margin of 8412 is about -2.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.